Clinical Trial Update: Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for the combination of darolutamide and abemaciclib in prostate cancer (metastatic and non-metastatic), currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nubeqa (darolutamide)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Praful Ravi, MB BCHir, MRCP | Conditions: Metastatic Prostate Cancer, Non-metastatic Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING